To determine whether modified mAb-KF retained target specificity, we stained CD33-positive acute myeloid leukemia THP1 cells and CD33-negative acute T cell leukemia Jurkat cells and performed flow cytometry analysis. Here, AFMID is linked to T-cell acute lymphoblastic leukemia.